Crohn's disease is most commonly diagnosed in adolescents or young adults, but it can strike at any age (even in children). Tough to diagnosis and often mistaken for other illnesses, Crohn's disease can cause diarrhea, gut pain, and even skin, joint, and eye problems. Read more about how you can get Crohn's disease under control with medication and lifestyle changes.
Conquering Crohn's DiseaseCrohn's disease is a form of inflammatory bowel disease that causes inflammation and ulcers that may affect the deepest layers of the lining of the digestive tract. It can also cause abnormal openings or connections (fistulas) in the diseased intestine.
Crohn's Disease News
SUNDAY, Oct. 19, 2014 (HealthDay News) — New stem cell-based research could improve understanding of intestinal diseases and eventually lead to new treatments, a new study suggests. Scientists used stem cells to grow “organoids” of functioning human intestinal tissue in a lab dish. They then transplanted the organoids into mice, creating a new model for studying [...]
By Alan MozesHealthDay Reporter FRIDAY, Oct. 3, 2014 (HealthDay News) — When given to pregnant women, a common treatment for ulcerative colitis may inadvertently lower their baby’s ability to fight off infections at birth, new French research suggests. The treatment, called anti-TNF therapy, is an injected, artificial antibody. This type of medication is widely seen as a [...]
WEDNESDAY, Aug. 27, 2014 (HealthDay News) — A new genetic discovery about Crohn’s disease could lead to different ways to fight the bowel disorder, researchers report. The scientists pinpointed chemical changes in Crohn’s patients’ DNA that affect how their genes work, and said these changes can be detected in blood samples. Along with raising the possibility [...]
By Dennis ThompsonHealthDay Reporter WEDNESDAY, June 18, 2014 (HealthDay News) — A popular class of drugs used to treat inflammatory bowel disease isn’t linked to an increase in the short-term risk of cancer, Danish researchers report. Researchers found that people with Crohn’s disease or colitis who received the drugs — tumor necrosis factor alpha (TNF-a) antagonists — [...]
A new drug to treat adults with ulcerative colitis and Crohn’s disease has been approved by the U.S. Food and Drug Administration.